Es gab 50 kürzliche Insider-Transaktionen für Kura Oncology, Inc. (KURA), darunter 30 Käufe und 20 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $20.15M und die gesamten Insider-Verkäufe auf $1.57M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Wilson Troy Edward, Malley Thomas, Ford Kathleen. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — KURA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-23 |
Wilson Troy Edward |
President and CEO |
Optionsausübung |
6,103 |
$6.15 |
$37.53K |
- |
| 2026-03-18 |
Malley Thomas |
Director |
Optionsausübung |
10,000 |
$3.12 |
$31.2K |
- |
| 2026-01-27 |
Ford Kathleen |
Chief Operating Officer |
Informierter Verkauf |
1,813 |
$8.46 |
$15.34K |
153,560 |
| 2026-01-27 |
Bair Teresa Brophy |
Chief Legal Officer |
Informierter Verkauf |
4,777 |
$8.46 |
$40.42K |
226,931 |
| 2026-01-27 |
Doyle Thomas James |
SVP, Finance & Accounting |
Informierter Verkauf |
881 |
$8.46 |
$7.45K |
145,167 |
| 2026-01-27 |
Powl Brian T. |
Chief Commercial Officer |
Informierter Verkauf |
1,572 |
$8.46 |
$13.3K |
183,275 |
| 2026-01-27 |
Leoni Mollie |
Chief Medical Officer |
Informierter Verkauf |
1,341 |
$8.46 |
$11.35K |
267,274 |
| 2026-01-27 |
Burrows Francis |
Chief Scientific Officer |
Informierter Verkauf |
1,311 |
$8.46 |
$11.09K |
32,424 |
| 2026-01-02 |
Wilson Troy Edward |
President and CEO |
RSU-Zuteilung |
1,120,000 |
$10.34 |
$11.58M |
1,120,000 |
| 2026-01-02 |
Ford Kathleen |
Chief Operating Officer |
RSU-Zuteilung |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Bair Teresa Brophy |
Chief Legal Officer |
RSU-Zuteilung |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Doyle Thomas James |
SVP, Finance & Accounting |
RSU-Zuteilung |
42,500 |
$10.34 |
$439.24K |
42,500 |
| 2026-01-02 |
Powl Brian T. |
Chief Commercial Officer |
RSU-Zuteilung |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Leoni Mollie |
Chief Medical Officer |
RSU-Zuteilung |
100,000 |
$10.34 |
$1.03M |
100,000 |
| 2026-01-02 |
Burrows Francis |
Chief Scientific Officer |
RSU-Zuteilung |
185,000 |
$10.34 |
$1.91M |
185,000 |
| 2025-12-18 |
Burrows Francis |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
35,000 |
$4.80 |
$168K |
- |
| 2025-12-09 |
Hasnain Faheem |
Director |
Informierter Verkauf |
10,000 |
$10.98 |
$109.76K |
23,983 |
| 2025-11-14 |
Ford Kathleen |
Chief Operating Officer |
Informierter Verkauf |
6,902 |
$11.18 |
$77.14K |
105,373 |
| 2025-11-14 |
Bair Teresa Brophy |
Chief Legal Officer |
Informierter Verkauf |
8,804 |
$11.18 |
$98.4K |
188,139 |
| 2025-11-14 |
Doyle Thomas James |
SVP, Finance & Accounting |
Informierter Verkauf |
4,539 |
$11.18 |
$50.73K |
130,257 |
| 2025-11-14 |
Powl Brian T. |
Chief Commercial Officer |
Informierter Verkauf |
8,887 |
$11.18 |
$99.33K |
139,689 |
| 2025-11-14 |
Leoni Mollie |
Chief Medical Officer |
Informierter Verkauf |
15,485 |
$11.18 |
$173.07K |
225,454 |
| 2025-11-13 |
Wilson Troy Edward |
President and CEO |
RSU-Zuteilung |
182,500 |
- |
- |
429,353 |
| 2025-11-13 |
Ford Kathleen |
Chief Operating Officer |
RSU-Zuteilung |
48,900 |
- |
- |
112,275 |
| 2025-11-13 |
Bair Teresa Brophy |
Chief Legal Officer |
RSU-Zuteilung |
48,900 |
- |
- |
196,943 |
| 2025-11-13 |
Doyle Thomas James |
SVP, Finance & Accounting |
RSU-Zuteilung |
24,967 |
- |
- |
134,796 |
| 2025-11-13 |
Powl Brian T. |
Chief Commercial Officer |
RSU-Zuteilung |
48,900 |
- |
- |
148,576 |
| 2025-11-13 |
Leoni Mollie |
Chief Medical Officer |
RSU-Zuteilung |
82,500 |
- |
- |
240,939 |
| 2025-09-29 |
Wilson Troy Edward |
President and CEO |
Informierter Verkauf |
36,615 |
$8.94 |
$327.42K |
246,853 |
| 2025-09-29 |
Ford Kathleen |
Chief Operating Officer |
Informierter Verkauf |
6,892 |
$8.94 |
$61.63K |
63,375 |
| 2025-09-29 |
Bair Teresa Brophy |
Chief Legal Officer |
Informierter Verkauf |
8,805 |
$8.94 |
$78.74K |
148,043 |
| 2025-09-29 |
Doyle Thomas James |
SVP, Finance & Accounting |
Informierter Verkauf |
4,541 |
$8.94 |
$40.61K |
109,829 |
| 2025-09-29 |
Powl Brian T. |
Chief Commercial Officer |
Informierter Verkauf |
8,891 |
$8.94 |
$79.51K |
99,676 |
| 2025-09-29 |
Leoni Mollie |
Chief Medical Officer |
Informierter Verkauf |
12,314 |
$8.94 |
$110.11K |
158,439 |
| 2025-09-27 |
Wilson Troy Edward |
President and CEO |
RSU-Zuteilung |
182,500 |
- |
- |
283,468 |
| 2025-09-27 |
Ford Kathleen |
Chief Operating Officer |
RSU-Rückgabe |
48,900 |
- |
- |
70,267 |
| 2025-09-27 |
Bair Teresa Brophy |
Chief Legal Officer |
RSU-Zuteilung |
48,900 |
- |
- |
156,848 |
| 2025-09-27 |
Doyle Thomas James |
SVP, Finance & Accounting |
RSU-Zuteilung |
24,966 |
- |
- |
114,370 |
| 2025-09-27 |
Powl Brian T. |
Chief Commercial Officer |
RSU-Zuteilung |
48,900 |
- |
- |
108,567 |
| 2025-09-27 |
Leoni Mollie |
Chief Medical Officer |
RSU-Zuteilung |
82,500 |
- |
- |
170,753 |
| 2025-09-08 |
Wilson Troy Edward |
President & CEO |
Informierter Kauf |
50,000 |
$8.20 |
$410.15K |
100,968 |
| 2025-08-13 |
Wilson Troy Edward |
President and CEO |
Informierter Kauf |
13,494 |
$6.64 |
$89.62K |
50,968 |
| 2025-08-12 |
Wilson Troy Edward |
President and CEO |
Informierter Kauf |
36,506 |
$5.85 |
$213.58K |
37,474 |
| 2025-06-05 |
Schafer Carol |
Director |
RSU-Zuteilung |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Hasnain Faheem |
Director |
RSU-Zuteilung |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Malley Thomas |
Director |
RSU-Zuteilung |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Szela Mary T |
Director |
RSU-Zuteilung |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Collins Helen Louise |
Director |
RSU-Zuteilung |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Vasconcelles Michael |
Director |
RSU-Zuteilung |
28,500 |
$6.57 |
$187.25K |
28,500 |
| 2025-06-05 |
Parks Diane L. |
Director |
RSU-Zuteilung |
28,500 |
$6.57 |
$187.25K |
28,500 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
